AstraZeneca

News

AstraZeneca searching for Pascal Soriot successor - report

AstraZeneca is looking for a successor to CEO Pascal Soriot just in case he decides to move on, according to a press report.

News

AstraZeneca's immunotherapy fails in key lung cancer trial

AstraZeneca’s immunotherapy combination including its checkpoint inhibitor drug Imfinzi has failed to improve overall survival in a first-line lung cancer trial – an indication where Merck

Digital

The future of pharma in a digital world

How is digital health impacting pharma? An exclusive live broadcast from Frontiers Health 2018 addressed this subject on 15 November.

Views & Analysis

AstraZeneca may have hit rock bottom, but can it rise to new...

Back in 2014, Pascal Soriot CEO of AstraZeneca managed to stave off a takeover bid from Pfizer with a bold promise to return the company to growth and achieve revenues of between $41 to $42 billion

News

AZ sells rights to RSV virus drug to Sobi for $1.5bn

AstraZeneca has agreed to sell the rights to its drug Synagis (palivizumab) to Swedish Orphan Biovitrum (Sobi) for an upfront $1.5 billion in cash and shares, plus certain conditional payme

News

US regulator grants fast review for AZ ovarian cancer drug

The US Food and Drug Administration (FDA) has granted AstraZeneca priority review for its ovarian cancer drug Lynparza – and the company has also revealed positive results for its diabetes

AstraZeneca searching for Pascal Soriot successor - report

AstraZeneca's immunotherapy fails in key lung cancer trial

The future of pharma in a digital world

AstraZeneca may have hit rock bottom, but can it rise to new...

AZ sells rights to RSV virus drug to Sobi for $1.5bn

US regulator grants fast review for AZ ovarian cancer drug

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

AstraZeneca

Editor's Picks